WallStSmart

Comfort Systems USA Inc (FIX)vsVertex Pharmaceuticals Inc (VRTX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Vertex Pharmaceuticals Inc generates 18% more annual revenue ($12.00B vs $10.14B). VRTX leads profitability with a 32.9% profit margin vs 12.1%. FIX appears more attractively valued with a PEG of 1.44. VRTX earns a higher WallStSmart Score of 66/100 (B-).

FIX

Buy

60

out of 100

Grade: C

Growth: 8.0Profit: 8.0Value: 4.3Quality: 6.3
Piotroski: 4/9Altman Z: 3.72

VRTX

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 9.0Value: 6.7Quality: 8.0
Piotroski: 3/9Altman Z: 3.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for FIX.

VRTXUndervalued (+56.0%)

Margin of Safety

+56.0%

Fair Value

$973.13

Current Price

$427.65

$545.48 discount

UndervaluedFair: $973.13Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FIX4 strengths · Avg: 9.3/10
Return on EquityProfitability
53.3%10/10

Every $100 of equity generates 53 in profit

Altman Z-ScoreHealth
3.7210/10

Safe zone — low bankruptcy risk

Market CapQuality
$64.78B9/10

Large-cap with strong market position

EPS GrowthGrowth
38.8%8/10

Earnings expanding 38.8% YoY

VRTX6 strengths · Avg: 9.5/10
Profit MarginProfitability
32.9%10/10

Keeps 33 of every $100 in revenue as profit

Operating MarginProfitability
39.6%10/10

Strong operational efficiency at 39.6%

Altman Z-ScoreHealth
3.6210/10

Safe zone — low bankruptcy risk

Market CapQuality
$108.71B9/10

Large-cap with strong market position

Return on EquityProfitability
22.5%9/10

Every $100 of equity generates 23 in profit

Debt/EquityHealth
0.219/10

Conservative balance sheet, low leverage

Areas to Watch

FIX3 concerns · Avg: 2.7/10
Revenue GrowthGrowth
1.0%4/10

1.0% revenue growth

P/E RatioValuation
53.2x2/10

Premium valuation, high expectations priced in

Price/BookValuation
109.6x2/10

Trading at 109.6x book value

VRTX3 concerns · Avg: 3.7/10
PEG RatioValuation
2.084/10

Expensive relative to growth rate

P/E RatioValuation
27.9x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : FIX

The strongest argument for FIX centers on Return on Equity, Altman Z-Score, Market Cap. PEG of 1.44 suggests the stock is reasonably priced for its growth.

Bull Case : VRTX

The strongest argument for VRTX centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 32.9% and operating margin at 39.6%.

Bear Case : FIX

The primary concerns for FIX are Revenue Growth, P/E Ratio, Price/Book. A P/E of 53.2x leaves little room for execution misses.

Bear Case : VRTX

The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

FIX profiles as a value stock while VRTX is a mature play — different risk/reward profiles.

FIX carries more volatility with a beta of 1.60 — expect wider price swings.

VRTX is growing revenue faster at 9.5% — sustainability is the question.

VRTX generates stronger free cash flow (349M), providing more financial flexibility.

Bottom Line

VRTX scores higher overall (66/100 vs 60/100), backed by strong 32.9% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Comfort Systems USA Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

Comfort Systems USA, Inc. provides mechanical and electrical installation, renovation, maintenance, repair and replacement services for the mechanical and electrical service industry in the United States. The company is headquartered in Houston, Texas.

Vertex Pharmaceuticals Inc

HEALTHCARE · BIOTECHNOLOGY · USA

Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.

Want to dig deeper into these stocks?